ALXO (STOCKS)
ALX Oncology Holdings Inc. Common Stock
$2.520000
-0.030000 (-1.18%)
Prev close: $2.550000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jason Lettmann
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $405.54M
- Employees
- 49
- P/E (TTM)
- -1.26
- P/B (TTM)
- 3.05
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.41 | $-0.37 | -0.0360 | -9.63% |
|
Jun 2025 (Q2)
|
$-0.43 | $-0.46 | +0.0290 | +6.32% |
|
Mar 2025 (Q1)
|
$-0.58 | $-0.47 | -0.1067 | -22.54% |
|
Dec 2024 (Q4)
|
$-0.55 | $-0.68 | +0.1334 | +19.52% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $111.61M |
| Depreciation and Amortization | $800.00K |
| Research and Development | $82.88M |
| Other Operating Expenses | $27.93M |
| Operating Income/Loss | -$111.61M |
| Income/Loss From Continuing Operations After Tax | -$108.01M |
| Income/Loss From Continuing Operations Before Tax | -$108.01M |
| Interest Expense, Operating | $1.65M |
| Net Income/Loss | -$108.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$108.01M |
| Net Income/Loss Available To Common Stockholders, Basic | -$108.01M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.01 |
| Diluted Earnings Per Share | -$2.01 |
| Basic Average Shares | 54,082,722 |
| Diluted Average Shares | 54,082,722 |
| Assets | $82.72M |
| Current Assets | $66.52M |
| Prepaid Expenses | $892.00K |
| Other Current Assets | $65.62M |
| Noncurrent Assets | $16.21M |
| Fixed Assets | $1.35M |
| Other Non-current Assets | $14.86M |
| Liabilities | $37.92M |
| Current Liabilities | $27.72M |
| Accounts Payable | $6.58M |
| Wages | $2.79M |
| Other Current Liabilities | $18.35M |
| Noncurrent Liabilities | $10.20M |
| Long-term Debt | $10.60M |
| Equity | $44.80M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $44.80M |
| Liabilities And Equity | $82.72M |
| Net Cash Flow From Operating Activities | -$97.21M |
| Net Cash Flow From Operating Activities, Continuing | -$97.21M |
| Net Cash Flow From Investing Activities | $104.54M |
| Net Cash Flow From Investing Activities, Continuing | $104.54M |
| Net Cash Flow From Financing Activities | $12.00K |
| Net Cash Flow From Financing Activities, Continuing | $12.00K |
| Net Cash Flow | $7.34M |
| Net Cash Flow, Continuing | $7.34M |
| Comprehensive Income/Loss | -$108.53M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$108.53M |
| Other Comprehensive Income/Loss | -$520.00K |